Natural history of decompensated hepatitis C virus-related cirrhosis.: A study of 200 patients

被引:229
作者
Planas, R [1 ]
Ballesté, B
Alvarez, MA
Rivera, M
Montoliu, S
Galeras, JA
Santos, J
Susanna, C
Morillas, RM
Sola, R
机构
[1] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Gastroenterol, Badalona, Spain
[2] Univ Autonoma Barcelona, Hosp del Mar, Liver Sect, E-08193 Barcelona, Spain
关键词
ascites; hepatic encephalopathy; portal hypertensive gastrointestinal bleeding; hepatocellular carcinoma; bacterial infection;
D O I
10.1016/j.jhep.2004.01.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Since few data are available concerning the clinical course of decompensated hepatitis C virus (HCV)-related cirrhosis, the aim of the present study was to define the natural long-term course after the first hepatic decompensation. Methods: Cohort of 200 consecutive patients with HCV-related cirrhosis, and without known hepatocellular carcinoma (HCC), hospitalized for the first hepatic decompensation. Results: Ascites was the most frequent first decompensation (48%), followed by portal hypertensive gastrointestinal bleeding (PHGB) (32.5%), severe bacterial infection (BI) (14.5%) and hepatic encephalopathy (HE) (5%). During follow-up (34+/-2 months) there were 519 readmissions, HCC developed in 33 (16.5%) patients, and death occurred in 85 patients (42.5%). The probability of survival after diagnosis of decompensated cirrhosis was 81.8 and 50.8 % at 1 and 5 years, respectively. HE and/or ascites as the first hepatic decompensation, baseline Child-Pugh score, age, and presence of more than one decompensation during follow-up were independently correlated with survival. Conclusions: Once decompensated HCV-related cirrhosis was established, patients showed not only a very high frequency of readmissions, but also developed decompensations different from the initial one. These results contribute to defining the natural course and prognosis of decompensated HCV-related cirrhosis. (C) 2004 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:823 / 830
页数:8
相关论文
共 32 条
[1]   Epidemiology of hepatitis C [J].
Alter, MJ .
HEPATOLOGY, 1997, 26 (03) :S62-S65
[2]  
ASCHER NL, 1994, HEPATOLOGY, V20, pS24
[3]   Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C [J].
Bennett, WG ;
Inoue, Y ;
Beck, JR ;
Wong, JB ;
Pauker, SG ;
Davis, GL .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (10) :855-+
[4]   Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding:: A meta-analysis [J].
Bernard, B ;
Grangé, JD ;
Khac, EN ;
Amiot, X ;
Opolon, P ;
Poynard, T .
HEPATOLOGY, 1999, 29 (06) :1655-1661
[5]   Prognostic significance of hepatic encephalopathy in patients with cirrhosis [J].
Bustamante, J ;
Rimola, A ;
Ventura, PJ ;
Navasa, M ;
Cirera, I ;
Reggiardo, V ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 1999, 30 (05) :890-895
[6]   A PROSPECTIVE-STUDY OF BACTERIAL-INFECTIONS IN PATIENTS WITH CIRRHOSIS [J].
CALY, WR ;
STRAUSS, E .
JOURNAL OF HEPATOLOGY, 1993, 18 (03) :353-358
[7]   Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis [J].
Chiba, T ;
Matsuzaki, Y ;
Abei, M ;
Shoda, J ;
Aikawa, T ;
Tanaka, N ;
Osuga, T .
JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) :552-558
[8]   HEPATOCELLULAR-CARCINOMA IN ITALIAN PATIENTS WITH CIRRHOSIS [J].
COLOMBO, M ;
DEFRANCHIS, R ;
DELNINNO, E ;
SANGIOVANNI, A ;
DEFAZIO, C ;
TOMMASINI, M ;
DONATO, MF ;
PIVA, A ;
DICARLO, V ;
DIOGUARDI, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (10) :675-680
[9]  
de Franchis R, 2000, J HEPATOL, V33, P846
[10]   Hepatitis C and alcohol [J].
Degos, F .
JOURNAL OF HEPATOLOGY, 1999, 31 :113-118